X4 PHARMACEUTICALS, INC (XFOR)

Import this data to Google Sheets with:

=jivedata("XFOR","financials")

Full statements spill as a table. For one cell: =jivedata("XFOR","Revenue") or =jivedata("XFOR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

X4 PHARMACEUTICALS, INC

XFOR • CIK 0001501697

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	—	$2,557	$35,113	$15,847
Operating Income (Loss)	$-107,522	$-36,401	$-86,883	$-87,905
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-101,089	$-37,140	$-79,158	$-90,166
Income Tax Expense (Benefit)	$78	$310	$41	$-28
Net Income (Loss) Attributable to Parent	$-101,167	$-37,450	$-79,199	$-90,138
Weighted Average Number of Shares Outstanding, Basic	177,812,480	201,062,211	42,292,818	161,513,495
Cost of Revenue	—	$797	$5,757	$2,930
Research and Development Expense	$72,017	$81,643	$72,723	$66,387
General and Administrative Expense	$35,505	$61,518	$43,516	$34,435
Gain (Loss) on Disposition of Intangible Assets	$0	$105,000	$0	$0
Investment Income, Interest	$4,582	$5,769	$4,576	$6,970
InterestExpenseNonoperating	—	$8,768	$8,876	$8,741
Derivative, Gain (Loss) on Derivative, Net	$7,074	$1,928	$12,778	$-86
Other Nonoperating Income (Expense)	$554	$332	$-753	$-404
Nonoperating Income (Expense)	$6,433	$-739	$7,725	$-2,261
Other Comprehensive Income (Loss), Net of Tax	—	—	$-79,186	$-90,123

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$99,216	$55,699	$217,049	$195,095
Accounts and Other Receivables, Net, Current	—	$1,070	$573	$2,047
Property, Plant and Equipment, Net	$745	$776	$182	$111
Marketable Securities	$15,000	$46,361	$35,949	$12,874
Goodwill	$17,351	$17,351	$17,351	$17,351
Finite-Lived Intangible Assets, Net	—	$10,000	$9,250	$13,101
Inventory, Gross	—	—	$4,479	$5,502
Operating Lease, Right-of-Use Asset	$5,650	$4,065	$1,409	$654
Prepaid Expense and Other Assets, Current	$7,298	$5,588	$3,527	$3,337
Other Assets, Noncurrent	$1,436	$2,080	$692	$2,991
Assets, Current	$122,076	$112,175	$261,577	$218,855
Assets	$147,258	$146,447	$290,461	$253,063
Operating Lease, Liability, Noncurrent	$2,612	$1,410	$0	$0
Derivative Liability, Noncurrent	$15,683	$13,755	$977	$369
Contract with Customer, Liability, Noncurrent	—	—	$621	$592
Other Liabilities, Noncurrent	$432	$831	$525	$523
Liabilities	$96,159	$124,298	$104,171	$97,609
Accounts Payable, Current	$8,947	$8,621	$5,696	$3,934
Accrued Liabilities, Current	$12,816	$23,005	$18,603	$14,125
Contract with Customer, Liability, Current	—	—	$464	$842
Operating Lease, Liability, Current	$1,099	$1,251	$994	$465
Liabilities, Current	$22,862	$32,877	$25,757	$19,366
Preferred Stock, Value, Issued	—	$0	$0	$0
Common Stock, Value, Issued	$167	$171	$91	$96
Additional Paid in Capital, Common Stock	$528,956	$537,455	$780,862	$786,433
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-119	$-122	$-109	$-123
Retained Earnings (Accumulated Deficit)	$-477,905	$-515,355	$-594,554	$-630,952
Stockholders' Equity Attributable to Parent	$51,099	$22,149	$186,290	$155,454
Preferred Stock, Shares Authorized	—	10,000,000	10,000,000	10,000,000
Preferred Stock, Shares Issued	—	0	0	0
Common Stock, Shares Authorized	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, Shares, Issued	167,434,595	170,946,943	90,906,920	96,114,534

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$-101,167	$-37,450	$-79,199	$-90,138
Net Cash Provided by (Used in) Operating Activities	$-96,512	$-130,901	$-85,618	$-83,736
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$99	$-156	$213	$-23
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-22,780	$-43,773	$161,377	$155,747
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$100,248	$56,475	$217,852	$394,298
Capital Expenditures Incurred but Not yet Paid	—	—	$500	$500
Interest Paid, Excluding Capitalized Interest, Operating Activities	$4,604	$7,766	$8,053	$8,053
Share-based Payment Arrangement, Noncash Expense	$8,687	$8,204	$4,298	$8,530
AssetAcquisitionConsiderationTransferredOtherAssets	—	—	$3,000	$5,000
Depreciation, Depletion and Amortization	$419	$796	$1,277	$1,666
Proceeds from Sales of Assets, Investing Activities	—	—	$0	$0
Gain (Loss) on Disposition of Intangible Assets	$0	$105,000	$0	$0
Payments to Acquire Marketable Securities	$16,823	$57,134	$63,388	$46,435
Proceeds from Sale and Maturity of Marketable Securities	$2,000	$26,450	$74,542	$57,867
Payments to Acquire Productive Assets	$60	—	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-14,883	$66,990	$8,154	$6,432
Other Noncash Income (Expense)	$227	$639	$161	$522
Proceeds from Stock Plans	—	—	$98	$128
Proceeds from Issuance of Other Long-term Debt	$22,500	$20,000	$0	$0
Repayments of Long-term Debt	$2,064	$0	$0	$0
Proceeds from Issuance of Common Stock	—	—	$238,530	$232,946
Net Cash Provided by (Used in) Financing Activities	$88,516	$20,294	$238,628	$233,074
Increase (Decrease) in Accounts Receivable	—	$1,070	$-497	$903
Increase (Decrease) in Inventories	—	$2,817	$1,662	$2,332
Increase (Decrease) in Prepaid Expense and Other Assets	$1,370	$-683	$-4,248	$-1,568
Increase (Decrease) in Accounts Payable	$1,234	$-286	$-2,979	$-3,776
Increase (Decrease) in Accrued Liabilities	$1,608	$7,169	$-2,025	$1,050
Increase (Decrease) in Contract with Customer, Liability	—	—	$1,085	$-147

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("XFOR","financials")

Full statements spill as a table. For one cell: =jivedata("XFOR","Revenue") or =jivedata("XFOR","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.